20/20 Biolabs, Inc. Common Stock (AIDX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

20/20 Biolabs, Inc. Common Stock (AIDX) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $4.9M, listed on NASDAQ, employing roughly 13 people, carrying a beta of -0.42 to the broader market. 20/20 GeneSystems, Inc. Led by Jonathan Cohen, public since 2023-06-15.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for AIDX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →